Relmada Therapeutics, Inc. (RLMD)
5.67
-0.05
(-0.87%)
USD |
NASDAQ |
Jun 09, 12:52
Relmada Therapeutics EPS Diluted (Quarterly) : -0.22 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Theravance Biopharma, Inc. | -0.0962 |
| Indivior Pharmaceuticals, Inc. | 0.6899 |
| ANI Pharmaceuticals, Inc. | 1.276 |
| Corcept Therapeutics, Inc. | -0.2988 |
| Assertio Holdings, Inc. | -2.931 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -19.05M |
| Total Expenses (Quarterly) | 19.05M |
| Enterprise Value | 366.01M |
| Earnings Yield | -19.62% |
| Normalized Earnings Yield | -19.60 |